These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The challenging patient: HCV and alcoholic liver disease. Lucey MR; Lake JR Liver Transpl; 2007 Nov; 13(11 Suppl 2):S87-8. PubMed ID: 17969072 [No Abstract] [Full Text] [Related]
25. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846 [TBL] [Abstract][Full Text] [Related]
26. Treatment of alcohol use disorder patients affected by liver cirrhosis and/or hepatocellular carcinoma awaiting liver transplantation. Testino G; Leone S; Borro P Minerva Med; 2016 Aug; 107(4):223-38. PubMed ID: 27148681 [TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation. Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211 [TBL] [Abstract][Full Text] [Related]
28. Nonalcoholic steatohepatitis and the metabolic syndrome. Jiang J; Torok N Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830 [TBL] [Abstract][Full Text] [Related]
29. Cytokines in alcoholic and nonalcoholic steatohepatitis. Tilg H; Diehl AM N Engl J Med; 2000 Nov; 343(20):1467-76. PubMed ID: 11078773 [No Abstract] [Full Text] [Related]
34. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. El Atrache MM; Abouljoud MS; Divine G; Yoshida A; Kim DY; Kazimi MM; Moonka D; Huang MA; Brown K Clin Transplant; 2012; 26(5):E505-12. PubMed ID: 23061759 [TBL] [Abstract][Full Text] [Related]